REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $68,000 | -41.4% | 4,175 | 0.0% | 0.01% | -47.8% |
Q3 2021 | $116,000 | -6.5% | 4,175 | 0.0% | 0.02% | -8.0% |
Q2 2021 | $124,000 | +6.0% | 4,175 | 0.0% | 0.02% | 0.0% |
Q1 2021 | $117,000 | -2.5% | 4,175 | 0.0% | 0.02% | -7.4% |
Q4 2020 | $120,000 | +14.3% | 4,175 | 0.0% | 0.03% | +12.5% |
Q3 2020 | $105,000 | -9.5% | 4,175 | -12.1% | 0.02% | +9.1% |
Q2 2020 | $116,000 | +65.7% | 4,750 | 0.0% | 0.02% | +46.7% |
Q1 2020 | $70,000 | -9.1% | 4,750 | 0.0% | 0.02% | 0.0% |
Q4 2019 | $77,000 | +83.3% | 4,750 | +46.2% | 0.02% | +50.0% |
Q3 2019 | $42,000 | 0.0% | 3,250 | 0.0% | 0.01% | +11.1% |
Q2 2019 | $42,000 | -17.6% | 3,250 | 0.0% | 0.01% | -30.8% |
Q1 2019 | $51,000 | +410.0% | 3,250 | +550.0% | 0.01% | +333.3% |
Q4 2018 | $10,000 | -16.7% | 500 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $12,000 | -14.3% | 500 | 0.0% | 0.00% | -25.0% |
Q2 2018 | $14,000 | -6.7% | 500 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $15,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |